Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04759846
Status:
WITHDRAWN
Last Update Posted:
2023-02-21
First Post:
2020-12-21
Brief Title:
Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma
Sponsor:
Pierre Fabre Medicament
Organization:
Pierre Fabre Medicament
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hepatic Impairment |
| BRAF V600 Mutation |
| Unresectable Melanoma |
| Metastatic Melanoma |
Keywords: